Skip Navigation

Cancer Treatment Centers of America - Chicago

Location

Cancer Treatment Centers of America - Chicago
Stem Cell Transplant and Cell Therapy Program
2520 Elisha Avenue
Zion, IL 60099
Direct phone: (888) 828-4888

Total transplants by cell source

From January 1, 2019 to December 31st, 2020
  • Marrow: 0
  • PBSC: 25
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 33
Performs adult transplants

Overview

The Hematologic Malignancies and Stem Cell Transplant Program at Cancer Treatment Centers of America® (CTCA), Chicago offers patients expertise in diagnosing and treating hematologic diseases using sophisticated technologies and therapies delivered through a personalized approach. The FACT accredited program provides standard-of-care and, when appropriate, advanced medical therapies for hematologic (blood) disorders, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes, in both an inpatient and outpatient environment. Once in treatment, patients and their families are cared for by a multidisciplinary team of experts and specialists led by a board-certified hematologic oncologist.

This center has been performing allogeneic transplants since 1998 and has been an NMDP/Be The Match transplant center since September 2011.

Attending physicians

Adult - Syed Abutalib, Istvan Redei

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Adult only

Other programs and services

Patients also have access to an array of integrative care services, such as nutrition, naturopathic, psychosocial and spiritual support, as well as other services focused on helping patients manage side effects, recover from treatment and improve quality of life. See https://www.cancercenter.com/locations/chicago for more information

About the center

Overview

The Hematologic Malignancies and Stem Cell Transplant Program at Cancer Treatment Centers of America® (CTCA), Chicago offers patients expertise in diagnosing and treating hematologic diseases using sophisticated technologies and therapies delivered through a personalized approach. The FACT accredited program provides standard-of-care and, when appropriate, advanced medical therapies for hematologic (blood) disorders, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes, in both an inpatient and outpatient environment. Once in treatment, patients and their families are cared for by a multidisciplinary team of experts and specialists led by a board-certified hematologic oncologist.

This center has been performing allogeneic transplants since 1998 and has been an NMDP/Be The Match transplant center since September 2011.

Attending physicians

Adult - Syed Abutalib, Istvan Redei

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Adult only

Other programs and services

Patients also have access to an array of integrative care services, such as nutrition, naturopathic, psychosocial and spiritual support, as well as other services focused on helping patients manage side effects, recover from treatment and improve quality of life. See https://www.cancercenter.com/locations/chicago for more information

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 39 patients.

The actual 1-year survival of these patients is 74.4%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 58.2% and 85.4%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Total transplants

Total transplants


58

Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 0 13 0 13
Unrelated donor 0 12 0 12
Total allogeneic 0 25 0 25
Autologous
Both marrow & PBSC
33
-- 33
Total combined
58 0 58

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 2 10 1 13
Unrelated 0 0 9 3 12
Autologous 0 3 21 9 33
Total 0 5 40 13 58

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Gilbert Punsalan
(888) 828-4888
Email: gilbert.punsalan@ctca-hope.com

Financial representative:
Nazima Khan
(847) 872-6111
Email: nazima.khan@ctca-hope.com

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program


No survivorship program information is available. Contact the center for information about post-transplant care.